|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 17439481 | EPO | EPO | 1.0 | Erythropoietin (EPO) EPO has recently been highlighted as a cytokine with various potent | |  |
| 17439481 | EPO | EPO | 1.0 | study was undertaken to evaluate the effect of recombinant human EPO (rhEPO) rhEPO on ALS model mice | | |
| 17582695 | EPO | EPO | 1.0 | Moreover low concentrations of EPO in CSF point to a rapid progression of disease that | | |
| 17439481 | erythropoietin | erythropoietin | 1.0 | recombinant human erythropoietin suppresses symptom onset and progression of g93a sod1 mouse model of als by preventing motor neuron death and inflammation. | | |
| 17439481 | erythropoietin | erythropoietin | 1.0 | erythropoietin epo has recently been highlighted as a cytokine with various potent neuroprotective effects including reduction of inflammation enhancement of survival signals and prevention of neuronal cell death. | | |
| 17439481 | erythropoietin | erythropoietin | 1.0 | erythropoietin recombinant|dinoprostone|superoxide dismutase 1|superoxide dismutase| | | |
| 17582695 | erythropoietin | erythropoietin | 1.0 | high erythropoietin and low vegf in csf from hypoxemic als patients suggest an abnormal response to hypoxia compared with hypoxic controls [26] . | | |